Hajime Kato, MD, PhD
Associate Research Scientist in Pathology
Research & Publications
Biography
Coauthors
Selected Publications
- Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review.Kato H, Kitamoto T, Kimura S, Sunouchi T, Hoshino Y, Hidaka N, Tsurutani Y, Ito N, Makita N, Nishikawa T, Nangaku M, Inoue K. Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review. Endocr Pract 2024 PMID: 38657793, DOI: 10.1016/j.eprac.2024.04.007.
- Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.Ito N, Hidaka N, Kato H. Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia. Endocrinol Metab (Seoul) 2024 PMID: 38467164, DOI: 10.3803/EnM.2023.1908.
- Extended curettage for tumour-induced osteomalacia in the bone.Okajima K, Kobayashi H, Ito N, Kato H, Ishibashi Y, Zhang L, Tsuda Y, Tanaka S. Extended curettage for tumour-induced osteomalacia in the bone. Jpn J Clin Oncol 2024 PMID: 38266040, DOI: 10.1093/jjco/hyad180.
- FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation AnalysisHidaka, N, Inoue, K, Kato, H. et al. FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis. JACC Adv. 2024 Jan, 3 (1) . https://doi.org/10.1016/j.jacadv.2023.100747
- Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice.Arima T, Sugimoto K, Taniwaki T, Maeda K, Shibata Y, Tateyama M, Karasugi T, Tokunaga T, Sueyoshi T, Hisanaga S, Masuda T, Uehara Y, Yugami M, Matsushita K, Yonemitsu R, Kawakami J, Yoshimura N, Tanimura S, Kato H, Ito N, Inoue K, Bando K, Nakamura T, Miyamoto T. Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice. J Biol Chem 2023, 105512. PMID: 38042486, DOI: 10.1016/j.jbc.2023.105512.
- The pathophysiology of hypophosphatemia.Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab 2023, 101851. PMID: 38087658, DOI: 10.1016/j.beem.2023.101851.
- The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia.Hidaka N, Murata H, Tachikawa K, Osaki K, Sekiyama T, Kinoshita Y, Kato H, Hoshino Y, Kimura S, Sunouchi T, Watanabe S, Nangaku M, Makita N, Michigami T, Ito N. The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia. JBMR Plus 2023, 7: e10842. PMID: 38130758, DOI: 10.1002/jbm4.10842.
- Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal LigamentsKato H, Braddock D, Ito N. Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments. Current Osteoporosis Reports 2023, 21: 552-566. PMID: 37530996, PMCID: PMC10543536, DOI: 10.1007/s11914-023-00814-6.
- The effect of burosumab on intact and C-terminal FGF23 measurements.Ashrafzadeh-Kian SL, Ito N, Srivastava T, Garg U, Kato H, Algeciras-Schimnich A, Bornhorst JA. The effect of burosumab on intact and C-terminal FGF23 measurements. Clin Endocrinol (Oxf) 2023, 99: 152-157. PMID: 36263608, DOI: 10.1111/cen.14832.
- FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review.Kato H, Kimura S, Taguchi M, Sunouchi T, Hoshino Y, Hidaka N, Edvige Foligno N, Koga M, Manaka K, Tamiya H, Kawakami M, Kage H, Yasunaga Y, Nangaku M, Makita N, Ito N. FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review. Endocr J 2023 PMID: 37468265, DOI: 10.1507/endocrj.EJ23-0086.
- Effect of Conventional Treatment on Dental Complications and Ectopic Ossifications Among 30 Adults With XLH.Kato H, Okawa R, Ogasawara T, Hoshino Y, Hidaka N, Koga M, Kinoshita Y, Kobayashi H, Taniguchi Y, Fukumoto S, Nangaku M, Makita N, Hoshi K, Nakano K, Ito N. Effect of Conventional Treatment on Dental Complications and Ectopic Ossifications Among 30 Adults With XLH. J Clin Endocrinol Metab 2023, 108: 1405-1414. PMID: 36524341, DOI: 10.1210/clinem/dgac732.
- Patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia.Kobayashi H, Ito N, Nakai Y, Katoh H, Okajima K, Zhang L, Tsuda Y, Tanaka S. Patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia. Bone Joint J 2023, 105-B: 568-574. PMID: 37121579, DOI: 10.1302/0301-620X.105B5.BJJ-2022-1206.R2.
- Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders.Ramos P, Larson B, Ashrafzadeh-Kian S, Ito N, Kato H, Bornhorst JA, Algeciras-Schimnich A. Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders. Endocr Pract 2023, 29: 193-198. PMID: 36627024, DOI: 10.1016/j.eprac.2023.01.003.
- Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia.Kato H, Miyazaki H, Kimura T, Hoshino Y, Hidaka N, Koga M, Nangaku M, Makita N, Ito N. Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia. Bone Rep 2023, 18: 101659. PMID: 36817167, DOI: 10.1016/j.bonr.2023.101659.
- Surgical and biochemical outcomes of phosphaturic mesenchymal tumors causing tumor-induced osteomalacia in the head and neck regionYusuke Tsuda, Yoichi Yasunaga, Masanobu Abe, Kazuto Hoshi, Nobuaki Ito, Kenji Kondo, Koichi Okajima, Liuzhe Zhang, Hajime Kato, Naoko Hidaka, Sakae Tanaka, Hiroshi Kobayashi, Surgical and biochemical outcomes of phosphaturic mesenchymal tumors causing tumor-induced osteomalacia in the head and neck region, Oral and Maxillofacial Surgery Cases, Volume 9, Issue 4, 2023, 100335
- Machine Learning-Based Prediction of Elevated PTH Levels Among the US General Population.Kato H, Hoshino Y, Hidaka N, Ito N, Makita N, Nangaku M, Inoue K. Machine Learning-Based Prediction of Elevated PTH Levels Among the US General Population. J Clin Endocrinol Metab 2022, 107: 3222-3230. PMID: 36125184, DOI: 10.1210/clinem/dgac544.
- Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.Kato H, Koga M, Kinoshita Y, Hidaka N, Hoshino Y, Takashi Y, Arai M, Kobayashi H, Katsura M, Nakamoto Y, Makise N, Ushiku T, Hoshi K, Nangaku M, Makita N, Fukumoto S, Ito N. Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors. J Endocr Soc 2022, 7: bvac181. PMID: 36540156, DOI: 10.1210/jendso/bvac181.
- A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene.Hofstaetter JG, Atkins GJ, Kato H, Kogawa M, Blouin S, Misof BM, Roschger P, Evdokiou A, Yang D, Solomon LB, Findlay DM, Ito N. A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene. Calcif Tissue Int 2022, 111: 430-444. PMID: 35618777, DOI: 10.1007/s00223-022-00988-8.
- Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.Hidaka N, Koga M, Kimura S, Hoshino Y, Kato H, Kinoshita Y, Makita N, Nangaku M, Horiguchi K, Furukawa Y, Ohnaka K, Inagaki K, Nakagawa A, Suzuki A, Takeuchi Y, Fukumoto S, Nakatani F, Ito N. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance. J Bone Miner Res 2022, 37: 1479-1488. PMID: 35690913, DOI: 10.1002/jbmr.4620.
- Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia.Koga M, Kinoshita Y, Kato H, Kobayashi H, Shinoda Y, Nangaku M, Makita N, Dahir KM, Ito N. Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia. Osteoporos Int 2022, 33: 505-509. PMID: 34494146, DOI: 10.1007/s00198-021-06145-5.
- Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system.Kato H, Hidaka N, Koga M, Ogawa N, Takahashi S, Miyazaki H, Nangaku M, Makita N, Ito N. Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system. J Bone Miner Metab 2022, 40: 101-108. PMID: 34351500, DOI: 10.1007/s00774-021-01258-7.
- Association of Serum Parathyroid Hormone Levels With All-Cause and Cause-Specific Mortality Among U.S. Adults.Kato H, Ito N, Makita N, Nangaku M, Leung AM, Inoue K. Association of Serum Parathyroid Hormone Levels With All-Cause and Cause-Specific Mortality Among U.S. Adults. Endocr Pract 2022, 28: 70-76. PMID: 34563702, DOI: 10.1016/j.eprac.2021.09.005.
- Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report.Kato H, Hidaka N, Koga M, Kinoshita Y, Makita N, Nangaku M, Ito N. Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report. Bone Rep 2021, 16: 101163. PMID: 35024386, DOI: 10.1016/j.bonr.2021.101163.
- Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa.Kato H, Hidaka N, Koga M, Kinoshita Y, Nangaku M, Makita N, Ito N. Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa. Int J Endocrinol 2021, 2021: 5492267. PMID: 34745256, DOI: 10.1155/2021/5492267.
- Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.Hidaka N, Kato H, Koga M, Katsura M, Oyama Y, Kinoshita Y, Fukumoto S, Makita N, Nangaku M, Ito N. Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption. Bone Rep 2021, 15: 101144. PMID: 34901334, DOI: 10.1016/j.bonr.2021.101144.
- Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia.Kato H, Koga M, Kinoshita Y, Taniguchi Y, Kobayashi H, Fukumoto S, Nangaku M, Makita N, Ito N. Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia. J Clin Endocrinol Metab 2021, 106: e3682-e3692. PMID: 33912912, DOI: 10.1210/clinem/dgab282.
- Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.Kato H, Koga M, Kobayashi H, Maki H, Ikemura M, Kurokawa M, Nangaku M, Makita N, Ito N. Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report. Osteoporos Int 2021, 32: 1013-1017. PMID: 33128574, DOI: 10.1007/s00198-020-05720-6.
- Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early‐Onset OsteoporosisKato H, Ansh AJ, Lester ER, Kinoshita Y, Hidaka N, Hoshino Y, Koga M, Taniguchi Y, Uchida T, Yamaguchi H, Niida Y, Nakazato M, Nangaku M, Makita N, Takamura T, Saito T, Braddock DT, Ito N. Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early‐Onset Osteoporosis. Journal Of Bone And Mineral Research 2020, 37: 1125-1135. PMID: 35340077, PMCID: PMC9177665, DOI: 10.1002/jbmr.4550.